Top Page
Science In Sport
(LSE:SIS)
Science In Sport (SIS) vs. iShares MSCI United Kingdom ETF (EWC)
Science In Sport Business Overview & Revenue Model
Science In Sport Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 51.88M | 62.67M | 63.77M | 62.54M | 50.35M | Gross Profit |
| 17.70M | 26.83M | 26.94M | 31.35M | 24.60M | EBIT |
| -3.60M | -9.73M | -9.82M | -5.22M | -2.19M | EBITDA |
| 2.17M | -3.70M | -5.15M | -1.82M | 846.00K | Net Income Common Stockholders |
| -4.74M | -11.28M | -10.91M | -6.82M | -1.73M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 1.97M | 2.14M | 930.00K | 4.85M | 10.47M | Total Assets |
| 66.69M | 70.30M | 75.70M | 73.93M | 62.95M | Total Debt |
| 15.68M | 23.85M | 21.78M | 12.41M | 860.00K | Net Debt |
| 13.71M | 21.70M | 20.85M | 7.56M | -9.61M | Total Liabilities |
| 33.89M | 41.23M | 35.41M | 29.85M | 14.90M | Stockholders Equity |
| 32.80M | 29.07M | 40.29M | 44.07M | 48.05M |
| Cash Flow | Free Cash Flow | |||
| -68.00K | 2.15M | -16.60M | -6.70M | 1.03M | Operating Cash Flow |
| 149.00K | 3.25M | -8.65M | -162.00K | 3.14M | Investing Cash Flow |
| -1.02M | -2.11M | -7.95M | -6.54M | -2.11M | Financing Cash Flow |
| 618.00K | 324.00K | 12.68M | 1.08M | 4.07M |
Science In Sport Technical Analysis
Science In Sport Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £1.73B | 14.04 | 9.02% | 0.86% | 5.90% | 11.24% | |
78 Outperform | £970.20M | 18.46 | 12.12% | 0.89% | 0.49% | 14.18% | |
75 Outperform | £1.25B | 22.61 | 9.10% | 4.41% | 4.03% | 3.21% | |
72 Outperform | £756.66M | 19.24 | 12.74% | 5.90% | -0.03% | 7.88% | |
67 Neutral | £68.33M | 16.52 | 11.76% | 2.64% | 23.22% | 81.79% | |
65 Neutral | $8.75B | 15.13 | 4.69% | 4.84% | 3.64% | -2.51% | |
58 Neutral | $77.13M | ― | -15.33% | ― | -17.22% | 62.78% |
Science In Sport Corporate Events
Science in Sport plc has announced that its 2025 Annual General Meeting is unlikely to occur due to a proposed cash acquisition by Einstein Bidco Limited. The company will still distribute the formal Notice of AGM for informational purposes, as it is expected that shareholders will no longer hold shares by the meeting date. This development signifies a significant change in the company’s ownership structure, potentially impacting its operations and market positioning.
Science in Sport (SiS) announced the approval of a recommended cash acquisition by Einstein Bidco Limited, a company indirectly owned by bd-capital Partners Limited. The acquisition, which will be executed through a scheme of arrangement, received the necessary shareholder approvals at both the Court Meeting and General Meeting. This development marks a significant step in the acquisition process, with the final court sanction expected on 12 June 2025. The acquisition is anticipated to impact SiS’s market position by aligning with bd-capital’s strategic interests, potentially benefiting stakeholders through enhanced resources and market reach.
Science in Sport PLC is set to be acquired by Einstein Bidco Limited, a company indirectly owned by funds advised by bd-capital Partners Limited, through a court-sanctioned scheme of arrangement. The acquisition involves a cash transaction for the entire share capital of Science in Sport, with certain shares initially intended for a different exchange now being transferred for cash due to ownership complexities. This acquisition is expected to streamline operations and potentially enhance the company’s market position, although it requires adjustments in share transfer agreements to align with the new ownership structure.
Science in Sport plc has announced a recommended cash acquisition by Einstein Bidco Limited, a company wholly-owned by funds advised by bd-capital Partners Limited. This acquisition will be executed through a Court-sanctioned scheme of arrangement. The agreement has received significant support, with irrevocable undertakings to vote in favor of the scheme from shareholders holding approximately 41.93% of SiS’s issued share capital. This acquisition is expected to impact SiS’s operations by aligning it with bd-capital’s strategic objectives, potentially enhancing its market positioning and providing value to stakeholders.
Science in Sport plc has published its 2024 Annual Report, highlighting its continued commitment to serving elite athletes and sports enthusiasts with premium performance nutrition products. The report underscores the company’s strong market presence through its dual-brand strategy, PhD Nutrition and SiS, and its extensive distribution channels, including digital platforms and international retail networks. This strategic positioning reinforces Science in Sport’s role as a key player in the sports nutrition industry, catering to a broad spectrum of consumers from professional athletes to the active lifestyle community.
Science in Sport plc reported its audited final results for the year ending December 31, 2024, showcasing a significant turnaround in its operating model despite a 17.2% drop in revenue to £51.9 million. The company achieved a notable 112.7% increase in underlying EBITDA to £4.2 million, reflecting improved profitability due to operational efficiencies and cost savings, including exiting uncommercial marketing contracts and restructuring its leadership team. The company completed an £8.5 million equity fundraising and amended banking facilities to support growth and profitability. Looking ahead, Science in Sport aims to continue its strategic focus on profitable revenue growth, margin improvements, and cash generation, with a recent agreement for an all-cash acquisition by bd Capital.
Science in Sport PLC has received a potential acquisition proposal from BD-Capital Partners Limited at 34 pence per share, which may lead to a full acquisition of the company’s share capital. An independent committee of the board is inclined to recommend the offer if a firm intention is announced, although discussions are still ongoing and no definitive offer has been made. The announcement has initiated an ‘offer period’ under the City Code on Takeovers and Mergers, with further developments expected by May 14, 2025.
Science in Sport PLC has confirmed receiving an approach from bd-capital Partners Limited for a potential acquisition at 34 pence per share. While the board is inclined to recommend the offer, discussions are still ongoing, and there is no certainty of a firm offer being made. Shareholders are advised to await further announcements, as the company enters an ‘offer period’ under the City Code on Takeovers and Mergers.